Clinical Trials Directory

Trials / Sponsors / Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd

Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd

Industry · 15 registered clinical trials — 7 currently recruiting.

StatusTrialPhaseStarted
RecruitingClinical Study of U32 in Patients With Acute Myeloid Leukemia
Acute Myeloid Leukaemia
Phase 1 / Phase 22025-07-03
RecruitingClinical Study of U29 Injection (CD30-CART) in Patients With CD30-Positive Relapsed/Refractory Lymphoma
Relapsed or Refractory Lymphoma
Phase 12025-03-04
RecruitingClinical Study of U01（ssCART-19） in Patients With B-Cell Lymphoma
B Cell Lymphoma
Phase 12025-01-23
RecruitingClinical Study of Multi-targeted CAR-T Therapy in Patients With Relapsed/Refractory B-Cell Lymphoma
B-cell Lymphoma
Phase 12024-11-07
RecruitingU87 CAR-T in Patients With Advanced Head and Neck Tumors
Nasopharynx Cancer, Head and Neck Cancer
Phase 12024-09-20
Not Yet RecruitingClinical Trial of ssCART-19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leuk
Relapsed or Refractory Acute Lymphoblastic Leukemia
Phase 22024-04-01
RecruitingClinical Study of U16 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Relapsed or Refractory Non-Hodgkin's Lymphoma
Phase 1 / Phase 22023-03-28
UnknownU87 CART in Treatment of Advanced Solid Tumor
Pancreatic Cancer, Solid Tumor, Adult
Phase 12022-10-19
UnknownClinical Study of ssCART-19 Cells in Patients With CD19 Positive Relapsed or Refractory Acute Lymphoblastic Le
Relapsed or Refractory Acute Lymphoblastic Leukemia
Phase 12021-04-09
UnknownPD-1 Silent PSMA/PSCA Targeted CAR-T for the Treatment of Prostate Cancer
Prostate Cancer
Phase 12018-08-02
UnknownCD19 Chimeric Antigen Receptors and CD19 Positive Feeder T Cells as a Leukemia Consolidation Treatment
Acute Lymphoblastic Leukemia in Remission
Phase 1 / Phase 22018-08-02
UnknownCART-19 T Cell in CD19 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)
Acute Myeloid Leukemia
Phase 1 / Phase 22017-10-18
UnknownCD19/CD22-targeted Chimeric Antigen Receptor Engineered T Cell (CART) in B-Cell Acute Lymphoblastic Leukemia.
Leukemia, B-cell
Phase 1 / Phase 22017-09-01
UnknownCD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic Leukemia
Acute Lymphoblastic Leukemia, CD19 Positive, Relapse
Phase 1 / Phase 22017-07-01
UnknownCAR-T Therapy for Central Nervous System B-cell Acute Lymphocytic Leukemia
B-cell Acute Lymphocytic Leukemia
Phase 12017-03-01